Drug Trial Radar · NCT05662306
C-Cog in Early Course Schizophrenia Study
Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Jan 23, 2024
Primary completion
Mar 3, 2025
Study completion Mar 3, 2025
Sponsor
- Lead sponsor
- University of MiamiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Alkermes, Inc.
- First posted
- Dec 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
Conditions
- Schizophrenia
Interventions
Aripiprazole LauroxilDrug
1064 mg 2-month long-acting injectable administered as an intramuscular injection over a 12-month period.
Computerized cognitive and functional skills trainingBehavioral
Self-administered cognitive and technology focused skills training, administered at home for 2 hours per week for the first 12 weeks of the 12-month study period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Percentage of Participants Who Develop Sustained Remission of Symptoms of Schizophrenia as Measured as Having a Score of 3 or Less on All 6 Critical Items From the Positive and Negative Syndrome Scale (PANSS)Time frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jackson Memorial Hospital
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.